The UK's Alpha variant became one of the most highly transmitted forms of the virus, which led to other variants mutating into existence - now, scientists are picking up on the beginnings of a "Mexican variant", yet to be named under the WHO system.
A team at Newcastle University have identified a gene, HLA-DRB1*04:01, which could be responsible for individuals who are asymptomatic - suggesting that the gene offers some protection against severe COVID.
The World Health Organisation (WHO) has given emergency approval to the Sinovac COVID-19 vaccine - because there is ongoing "access inequity" for countries in the Global South.
Richie Kohman, Synthetic Biology Platform Lead, Wyss Institute at Harvard, tells us all about Next Generation Sequencing in analysing synthetic biology signatures in brain tissue.
The WHO has renamed COVID variants of concern, as they believe that the scientific names can be "difficult" to use - leading to both misreporting and potential discrimination against countries of origin.
Steven Shepherd, Healthcare Director, SAS UK, explores how upgrades can be made in a way that is cost-efficient and where the NHS professionals asked to use those systems are comfortable with the upgrades.
Adapting their existing digital framework, SymlConnect address the severe outpatient waiting list backlog created by the impact of the COVID-19 pandemic, to enable secure patient-clinician remote communication.
Mike Sanders, Chief Executive Officer at Vital Hub UK Group of Companies, explains the importance of delivering sustainable solutions for healthcare in support of the whole patient journey beyond COVID-19.
New mathematical modelling from the University of Utah suggests that all severe COVID infections will disappear over the next ten years - if the global population has access to vaccination.
